Healthcare Success

  The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 Million by 2021 from USD 202.8 Million in 2016, at a CAGR of around 10.5% during the forecast period. The overall market, by public health organization is positively impacted by factors such as the growing expenditure on drugs and medical devices by public health organizations, government initiatives to strengthen analytical testing capabilities, increasing number of drug approvals & clinical trials, and rising demand for specialized analytical testing services. However, complex and innovative pharmaceutical products requiring a distinctive analytical testing approach is the major challenge hampering the growth of government support on analytical laboratory services. On the basis of type of service, the spend assessment is segmented into eight segments, namely, bioanalytical testing, batch release testing, stability testing, raw material testing, physical characte...

  The pharmacy automation systems market was mainly dominated by McKesson Corporation and CareFusion Corporation, collectively holding around half of the global market share in 2013. Besides McKesson and CareFusion, none of the other major players in the market have a share of more than 15%. However, there are a limited number of local players in the market that cater to their respective domestic and regional markets. In the past few years, growing competition from companies like Cerner, Omnicell, InterMetro, Baxter, and Swisslog has challenged the market dominance of the top two players. With a strong distribution network as well as a strong retail pharmacy solutions portfolio, Cerner Corporation is also emerging as one of the leading players in the pharmacy automation systems market. The leading position of McKesson can mainly be attributed to its well-established position in the pharmaceutical distribution business in the U.S. and Canada as well as its strong portfolio of pharma...

  The pharmaceutical robots market is dominated by Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group s.p.a (Italy), Universal Robots A/S (Denmark), Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan). Marketing and promotions; expansions; agreements, alliances, collaborations, & partnerships; and product launches were the major strategies adopted by key players to achieve growth in this market. Marketing and promotions accounted for 31.4% of the total strategies adopted by the players in this market. This strategy was adopted by players to increase their presence in the market. The key players that adopted this strategy are Kawasaki Heavy Industries Ltd. (Japan), KUKA AG (Germany), Seiko Epson Corporation (Japan), Marchesini Group s.p.a (Italy), and Universal Robots A/S (Denmark). For ...

  The global healthcare BPO market is projected to reach USD 468.5 billion by 2026 from USD 296.4 billion in 2021, at a CAGR of 9.6% during the forecast period. Healthcare BPO is a practice in which healthcare organizations outsource their business operations to third-party organizations. The need to reduce rising healthcare costs, increasing demand for niche services and need for structured processes and documentation are compelling payers and providers to outsource their business processes to low-cost countries in order to reduce their operational costs. On the other hand, the fear of losing visibility and control over business processes and data security and privacy concerns are the major factors expected to restrain the market growth. Some of the prominent players operating in the Healthcare BPO market are Accenture (Ireland), Cognizant (US), Tata Consultancy Services (India), Xerox Corporation (US), WNS (Holdings) Limited (India), NTT Data Corporation (Japan), IQVIA (US), Mpha...

  The pharmacy automation systems market was mainly dominated by McKesson Corporation and CareFusion Corporation, collectively holding around half of the global market share in 2013. Besides McKesson and CareFusion, none of the other major players in the market have a share of more than 15%. However, there are a limited number of local players in the market that cater to their respective domestic and regional markets. In the past few years, growing competition from companies like Cerner, Omnicell, InterMetro, Baxter, and Swisslog has challenged the market dominance of the top two players. With a strong distribution network as well as a strong retail pharmacy solutions portfolio, Cerner Corporation is also emerging as one of the leading players in the pharmacy automation systems market. The leading position of McKesson can mainly be attributed to its well-established position in the pharmaceutical distribution business in the U.S. and Canada as well as its strong portfolio of pharma...

  The global biologics safety testing market is projected to reach USD 6.2 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 12.4% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination, and rising biopharmaceuticals R&D activities and investments. In addition, emerging markets and increasing biopharmaceutical outsourcing are expected to provide significant growth opportunities for players in the Biologics safety testing market. Prominent players in the biologics safety testing market are Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), and Eurofins Scientific (Luxembourg). The key players in this market are focusing on strategic expansions, partnerships, and product launches and approvals to expand ...